157 research outputs found

    stajichlab/chytropsin: Ahrendt PeerJ 2017 S.punctatus

    No full text
    <p>This is the code and models associated with the publication Ahrendt et al "Exploring the binding properties and structural stability of an opsin in the chytrid <em>Spizellomyces punctatus</em> using comparative and molecular modeling" Preprint at DOI: <a href="http://dx.doi.org/10.7287/peerj.preprints.2397v1">10.7287/peerj.preprints.2397v1</a></p&gt

    Indications for non‐transplant surgery in primary sclerosing cholangitis

    No full text
    AbstractPrimary sclerosing cholangitis (PCS) is a progressive disease leading to secondary biliary cirrhosis. Patients are at increased risk of developing cholangiocarcinoma, which is usually diagnosed at an advanced stage. Treatment of PCS includes medical therapy, endoscopic biliary dilation, percutaneous transhepatic stenting, extrahepatic biliary resection and liver transplantation. The most effective management of primary sclerosing cholangitis before the onset of cirrhosis remains unclear. Non‐transplant surgical procedures have a limited but defined role in patients with PCS. Resection of the extrahepatic biliary tree in symptomatic non‐cirrhotic patients improves hyperbilirubinaemia and prolongs both transplant‐free and overall survival when compared with non‐operative dilation and/or stenting. Surgical resection may also definitively establish or exclude a diagnosis of cholangiocarcinoma in patients with dominant extrahepatic or perihilar strictures. Extrahepatic bile duct resection may also reduce the risk of cholangiocarcinoma. Extrahepatic biliary resection should be considered in selected non‐cirrhotic patients with symptomatic biliary obstruction and dominant extrahepatic and/or perihilar strictures. Those patients in whom cholangiocarcinoma is suspected should also undergo resection

    A History of the Bilioenteric Anastomosis

    No full text

    Principles of Surgical Therapy

    No full text

    Gene expression heatmaps

    No full text
      *Color coding used in Heatmaps: High expression (red),low expression (blue) *Upregulated genes (green), downregulated genes (violet) This folder contains additional supplementary files (gene expression heatmaps for different gene groups/families in 6 RNA-Seq experiments) used in the manuscript: Genomic innovation and horizontal gene transfer shaped plant colonization and biomass degradation strategies of a globally prevalent fungal pathogen Neha Sahu, Boris Indic, Johanna Wong-Bajracharya, Zsolt Merényi, Huei-Mien Ke, Steven Ahrendt, Tori-Lee Monk, Sándor Kocsubé, Elodie Drula, Anna Lipzen, Balázs Bálint, Bernard Henrissat, Bill Andreopoulos, Francis M. Martin, Christoffer Bugge Harder, Daniel Rigling, Kathryn L. Ford, Gary D. Foster, Jasmyn Pangilinan, Alexie Papanicolaou, Kerrie Barry, Kurt LaButti, Máté Virágh, Maxim Koriabine, Mi Yan, Robert Riley, Simang Champramary, Krista L. Plett, Igor V. Grigoriev, Isheng Jason Tsai, Jason Slot, György Sipos, Jonathan Plett, László G. Nagy bioRxiv 2022.11.10.515791; doi: https://doi.org/10.1101/2022.11.10.515791</p

    Gene trees

    No full text
    *Color coding used in gene trees: Physalacriaceae (green), other Basidiomycota (blue), Ascomycota (red), early diverging fungi (black) *Horizontal transfer events are highlighted by yellow clades This folder contains additional supplementary files (gene trees showing clades with horizontal gene transfer events - Table S4) used in the manuscript:   Genomic innovation and horizontal gene transfer shaped plant colonization and biomass degradation strategies of a globally prevalent fungal pathogen Neha Sahu, Boris Indic, Johanna Wong-Bajracharya, Zsolt Merényi, Huei-Mien Ke, Steven Ahrendt, Tori-Lee Monk, Sándor Kocsubé, Elodie Drula, Anna Lipzen, Balázs Bálint, Bernard Henrissat, Bill Andreopoulos, Francis M. Martin, Christoffer Bugge Harder, Daniel Rigling, Kathryn L. Ford, Gary D. Foster, Jasmyn Pangilinan, Alexie Papanicolaou, Kerrie Barry, Kurt LaButti, Máté Virágh, Maxim Koriabine, Mi Yan, Robert Riley, Simang Champramary, Krista L. Plett, Igor V. Grigoriev, Isheng Jason Tsai, Jason Slot, György Sipos, Jonathan Plett, László G. Nagy bioRxiv 2022.11.10.515791; doi: https://doi.org/10.1101/2022.11.10.515791</p

    Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis

    No full text
    Background: Neoadjuvant treatment is important for improving the rate of R0 surgical resection and overall survival outcome in treating patients with pancreatic ductal adenocarcinoma (PDAC). However, the true efficacy of radiotherapy (RT) for neoadjuvant treatment of PDAC is uncertain. This retrospective study evaluated the treatment outcome of neoadjuvant RT in the treatment of PDAC. Methods: Collected from the National Cancer Database, information on patients with PDAC who underwent neoadjuvant chemotherapy (NAC) and pancreatectomy between 2010 to 2016 was used in this study. Short- and long-term outcomes were compared between patients who received neoadjuvant chemoradiotherapy (NACRT) and NAC. Results: The study included 6936 patients, of whom 3185 received NACRT and 3751 NAC. The groups showed no difference in overall survival (NACRT 16.1 months versus NAC 17.4 months; P = 0.054). NACRT is associated with more frequent margin negative resection (86.1 versus 80.0 per cent; P < 0.001) but a more unfavourable 90-day mortality than NAC (6.4 versus 3.6 per cent; P < 0.001). The odds of 90-day mortality were higher in the radiotherapy group (odds ratio 1.81; P < 0.001), even after adjusting for significant covariates. Patients who received NACRT received single-agent chemotherapy more often than those who received NAC (31.5 versus 10.7 per cent; P < 0.001). Conclusion: This study failed to show a survival benefit for NACRT over NAC alone, despite its association with negative margin resection. The significantly higher mortality in NACRT warrants further investigation into its efficacy in the treatment of pancreatic cancer

    Effect of nicotine and muscle performance using a Wingate Anaerobic Test on collegiate football players

    No full text
    Nicotine is a naturally occurring addictive alkaloid and in some cases, a lethal drug. The long-term harmful effects of nicotine have been widely documented through means of publications, commercials and even billboards to stop the use of nicotine in the form of tobacco. Even with the knowledge of these harmful side effects, thousands of athletes still use tobacco. In this study the use of nicotinic substances was tested during Wingate Anaerobic Tests (WAnT) on collegiate football athletes. These tests had three possible outcomes: ergogenic, ergolytic or no effect. The subjects were 12 University of Wisconsin – Whitewater football players between the ages of 19 - 23. They performed a series of two tests on a Monarch cycle ergometer for 30 seconds at a time on two separate days. One day post-nicotine gum administration; the other day post-placebo gum administration. The data received was considered significant with a p-value < .05. This experiment showed nicotine’s effect on: peak anaerobic power (P = .34), anaerobic capacity (P = .92), and anaerobic fatigue percentage (P = .33) in the human body during a WAnT. Therefore, the data received from this experiment were concluded not to be statistically significant
    corecore